{
    "paper_id": "PMC7103730",
    "metadata": {
        "title": "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)",
        "authors": [
            {
                "first": "Taisheng",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Front-line medical personnel are qualified only after passing the physical examinations and professional training of SARS-CoV-2. Staff with the following conditions are exempt from SARS-CoV-2 related clinical/laboratory work, including pregnancy, age over 55 years old, a past history of chronic diseases such as chronic hepatitis, renal diseases, diabetes mellitus, autoimmune diseases and tumours. Individuals affected with acute fever should also be excluded from SARS-CoV-2 related work.",
            "cite_spans": [],
            "section": "Selection of front-line personnel ::: Protection requirements of medical personnel",
            "ref_spans": []
        },
        {
            "text": "Baseline tests should be arranged including the complete blood count, urine analysis, biochemical tests, creatine kinase, and chest X-ray.",
            "cite_spans": [],
            "section": "Selection of front-line personnel ::: Protection requirements of medical personnel",
            "ref_spans": []
        },
        {
            "text": "See \u201cThe guidelines for the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection (Pilot 3rd version)\u201d published by the National Health Commission of the People\u2019s Republic of China [1].",
            "cite_spans": [
                {
                    "start": 224,
                    "end": 225,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Isolation and protection requirements ::: Protection requirements of medical personnel",
            "ref_spans": []
        },
        {
            "text": "Medical personnel in close contact with SARS-CoV-2 infected pneumonia patients should be relatively isolated, avoiding walking around and extensive contact with others.Medical personnel should be isolated immediately and receive relevant examinations upon onset of fever, cough, shortness of breath and other symptoms.When work in the SARS-CoV-2 infection ward is finished, nasopharyngeal or oropharyngeal swabs for SARS-CoV-2 and a complete blood count should be carried out. Those who have abnormal test results should undergo strict isolation and observation; while others will be generally isolated for observation and resume work after one week.",
            "cite_spans": [],
            "section": "Isolation and observation of medical personnel after close contact with SARS-CoV-2 ::: Protection requirements of medical personnel",
            "ref_spans": []
        },
        {
            "text": "Epidemiological history: History of travel or residence in Hubei province within 2 weeks prior to the onset of illness, or contact with patients from Hubei province with fever and respiratory symptoms within 14 days prior to onset, or presented with clustering onset.Acute onset of fever within 72 h without influenza-like symptoms, which could not attribute to other confirmed etiology.",
            "cite_spans": [],
            "section": "Screening criteria [1\u20132CIT0001bibr] ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Supportive epidemiological historyClinical manifestation: Fever; normal or low levels of white blood cells or decreased lymphocyte counts at onset. Chest radiology at early stage is characteristic of multiple small patchy shadows and interstitial changes, more prominent in the extrapulmonary bands. Multiple ground-glass opacities and infiltrations may develop bilaterally with disease progression, with possible consolidation in severe cases.Diagnosis: SARS-CoV-2 nucleic acid positive in samples of sputum, pharynx swabs, and secretions of lower respiratory tract tested by real-time reverse-transcriptase\u2013polymerase-chain reaction (rRT-PCR) assay.For patients with acute fever (>37.5\u00b0C within 72 hours) and normal chest imaging, if the absolute count of peripheral lymphocytes is less than 0.8 \u00d7 109/L, or the count of CD4+ and CD8+ T cells decreases significantly, isolation and close observation should be conducted at home even if the first SARS-CoV-2 nucleic acid test is negative. Repeat of rRT-PCR should be considered after 24 h, and a chest CT scan should be performed when necessary.",
            "cite_spans": [],
            "section": "Diagnostic criteria ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Nucleic acid examination of sputum or naso-/oropharyngeal swabs, complete blood count, urine analysis, arterial blood gas analysis, liver and kidney function, C-reactive protein (CRP), procalcitonin, creatine kinase plus myoglobin, coagulation, and chest CT should be performed. Inflammatory cytokines [such as interleukin (IL)-6, IL-10, and tumour necrosis factor (TNF)-\u03b1], TB lymphocyte subsets, and complement can be tested as appropriate [3\u20135].",
            "cite_spans": [
                {
                    "start": 443,
                    "end": 446,
                    "mention": "3\u20135",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Screening cases on the day of visit ::: Examination routines of SARS-CoV-2 infected patient ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Complete blood count, liver and kidney function, creatine kinase and myoglobin, coagulation function and CRP can be checked on the 3rd, 5th and 7th days after admission and on discharge according to the disease status. PCT and TB lymphocyte subsets can be repeated on days 5\u20137 if feasible [3\u20135].The chest X-ray or CT scan should be re-examined 1\u20132 days after the admission, and the time for subsequent re-examination depends on the disease status, no longer than 5 days.Complete blood count, chest X-ray, liver and kidney function, and all abnormal examinations on admission should be re-examined before discharge except for referrals.",
            "cite_spans": [
                {
                    "start": 290,
                    "end": 293,
                    "mention": "3\u20135",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Sequential examination of confirmed patients ::: Examination routines of SARS-CoV-2 infected patient ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "According to the definition of the National Health Commission [1], patients in accordance with one of the following standards should be hospitalized and transferred to Beijing designated medical institution as soon as possible; (1) respiratory rate increased (\u226530 per min) or dyspnoea; (2) oxygen saturation \u2264 95% when breathing ambient air, or arterial oxygen tension (PaO\u2082) over inspiratory oxygen fraction (FIO\u2082) of less than 300 mm Hg (1 mm Hg equals to 0.133 kPa); (3) lung imaging indicating multilobular lesions or progression of lesions over 50% within 48 h; (4) quick sequential organ failure assessment (qSOFA) score \u22652; (5) community-acquired pneumonia-65 (CURB-65) score \u2265 1; (6) combined pneumothorax; (7) other clinical conditions that require hospitalization.",
            "cite_spans": [
                {
                    "start": 63,
                    "end": 64,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Severe type ::: Place of treatment according to the severity of the disease ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "According to the definition of the National Health Commission [1], patients in accordance with respiratory failure, septic shock or other organ failure should be transferred to intensive care unit immediately and to designated medical institution as soon as possible when feasible.",
            "cite_spans": [
                {
                    "start": 63,
                    "end": 64,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                }
            ],
            "section": "Critically ill type ::: Place of treatment according to the severity of the disease ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Patients should be kept in bed and closely monitored for vital signs and levels of oxygen saturation. Supportive treatment should be ensured, including enough supply of energy and fluid, maintenance of electrolyte and acid\u2013base homeostasis.",
            "cite_spans": [],
            "section": "General treatment ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Patients with mild hypoxemia should be put on nasal cannula, 5 L/min. If the patient is getting worse, high flow nasal cannula should be considered, starting with 20 L/min and increasing to 50\u201360 L/min gradually. Fraction of oxygen should be adjusted according to oxygen saturation.",
            "cite_spans": [],
            "section": "Choice of oxygen therapy ::: Oxygen therapy ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Non-invasive ventilation is only considered for patients who can tolerate. For the patients requiring invasive ventilation, endotracheal intubation should be performed by experienced physician with personal protective equipment.",
            "cite_spans": [],
            "section": "The way of respiratory support ::: Oxygen therapy ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "We recommend protective ventilation strategy for acute respiratory distress syndrome (ARDS). For those patients with most severe ARDS, extracorporeal membrane oxygenation or prone position is recommended. Interventions should be implemented to prevent complications associated with critical illness. Standard precautions should always be routinely applied in all areas of healthcare facilities.",
            "cite_spans": [],
            "section": "The way of respiratory support ::: Oxygen therapy ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Currently, there is no evidence to support the effectiveness of existing antiviral drugs against SARS-CoV-2. Lopinavir/ritonavir can be used when appropriate, 2 tablets, twice daily for 14 days.",
            "cite_spans": [],
            "section": "Antiviral treatment ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Severe patients could receive glucocorticoid at early stage, e.g. intravenous methylprednisolone 40\u201380 mg, once daily for 5 days, and the course of treatment can be prolonged according to the clinical condition and radiological manifestations.",
            "cite_spans": [],
            "section": "Glucocorticoid therapy ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Early intravenous infusion of human immunoglobulin is recommended for critically ill patients, based on their clinical condition, at 0.25\u20130.5 g/(kg\u00b7d), for 3\u20135 days [6\u20137].",
            "cite_spans": [
                {
                    "start": 166,
                    "end": 169,
                    "mention": "6\u20137",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Intravenous immunoglobulin ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "If bacterial infection is suspected according to the patient's clinical and imaging findings, patients of mild type can take oral antibiotics for community-acquired pneumonia, such as second-generation cephalosporins or fluoroquinolones. As regards patients of severe type, all possible pathogens should be covered when necessary.",
            "cite_spans": [],
            "section": "Empirical antimicrobial therapy ::: Treatment ::: Diagnosis and treatment of SARS-CoV-2 infected patients",
            "ref_spans": []
        },
        {
            "text": "Once the critically ill patients are diagnosed and endotracheal intubation is anticipated, they should be immediately transferred to the ICU ward with negative pressure. All the procedures should be carried out in accordance with the requirements of comprehensive protection.Oxygen storage mask is used to supply oxygen above 15 L/min during transport, during which complete filling of the oxygen storage airbag should be ensured.Endotracheal intubation should be induced by standard rapid procedure, and muscle relaxants should be used as much as possible to avoid droplet transmission caused by choking.Reusable items such as goggles should be disinfected after intubation before taken out of the negative pressure ward.Patients with intubation should use closed endotracheal suction to avoid airborne transmission caused by ventilator airflow.Under certain circumstances when the ventilator must be disconnected for operation, the standby function of the ventilator should be set to avoid airborne transmission caused by ventilator airflow. Once the standby function is not available, the Y-tube port of the ventilator should be blocked to avoid air spread.",
            "cite_spans": [],
            "section": "Protection and transfer",
            "ref_spans": []
        },
        {
            "text": "Patients could be discharged or transferred to the other departments for comorbidities, when the body temperature returned to normal for more than 3 days, the respiratory symptoms significantly improved, the pulmonary lesions markedly absorbed, and respiratory nucleic acid is tested negative for SARS-CoV-2 for two consecutive times at least 1 day apart.",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Wrote by",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Taisheng Li (Department of Infectious Diseases, Peking Union Medical College Hospital).",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Wei Cao (Department of Infectious Diseases, Peking Union Medical College Hospital).",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Li Weng (Department of Internal Medicine ICU, Peking Union Medical College Hospital).",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Hongwei Fan (Department of Infectious Diseases, Peking Union Medical College Hospital).",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Juhong Shi (Department of Respiratory and Critical Medicine, Peking Union Medical College Hospital).",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Experts participating in the discussion (sorted by family name of Chinese Phonetic Alphabet)",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        },
        {
            "text": "Wenzhao Chai, Bin Du, Na Guo, Ding Han, Yang Han, Xiaoyun Hu, Yang Jiao, Zhengyu Jin, Zhengyin Liu, Yun Long, Xiaojun Ma, Huizhen Wang, Mengzhao Wang, Xinming Wu, Yingchun Xu, Wenbing Xu, Bo Zhang, Fengchun Zhang, Shengjie Zhang, Huadong Zhu",
            "cite_spans": [],
            "section": "Criteria of isolation release and discharge [#!start#1#!sep#CIT0001#!sep#bibr#!end#]",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Rapid loss of both CD4+ and CD8+ T lymphocyte subsets during the acute phase of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Qiu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Han",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Chin Med J (Engl)",
            "volume": "116",
            "issn": "7",
            "pages": "985-987",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "The alterations of T cell subsets of severe acute respiratory syndrome during acute phase",
            "authors": [
                {
                    "first": "LI",
                    "middle": [],
                    "last": "Tai-sheng",
                    "suffix": ""
                },
                {
                    "first": "QIU",
                    "middle": [],
                    "last": "Zhi-feng",
                    "suffix": ""
                },
                {
                    "first": "HAN",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Chin J Lab Med",
            "volume": "26",
            "issn": "5",
            "pages": "297-299",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Taoran",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Taisheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Chin J Internal Med",
            "volume": "59",
            "issn": "3",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3760/cma.j.issn.0578-1426.2020.03"
                ]
            }
        },
        "BIBREF5": {
            "title": "Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain\u2013Barr\u00e9 syndrome",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Mori",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Parizot",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Dorgham",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "PLoS One",
            "volume": "3",
            "issn": "5",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pone.0002109"
                ]
            }
        },
        "BIBREF6": {
            "title": "Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases",
            "authors": [
                {
                    "first": "VG.",
                    "middle": [],
                    "last": "Hemming",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Clin Diagn Lab Immunol",
            "volume": "8",
            "issn": "5",
            "pages": "859-863",
            "other_ids": {
                "DOI": [
                    "10.1128/CDLI.8.5.859-863.2001"
                ]
            }
        }
    }
}